Welcome to UCARE Conference 2025

Join us for an unforgettable three-day journey into the world of chronic urticaria and related conditions—where science, collaboration, and innovation come together.

This exciting event features a robust scientific program, including ten sessions packed with oral presentations, cutting-edge lectures from world-renowned experts, dynamic workshops, and highly interactive poster sessions. Whether you’re a researcher, clinician, or healthcare professional, there’s something here to inspire and inform.

With more than 300 participants expected from over 50 countries, you’ll enjoy unparalleled opportunities to network, share insights, and engage in meaningful discussions with peers who are just as passionate about urticaria and mast cell-driven diseases as you are.

What’s more, you’ll gain firsthand access to the latest breakthroughs in urticaria pathogenesis, subtypes, biomarkers, comorbidities, diagnostics, and treatment innovations. In addition, our sessions offer practical, evidence-based strategies that you can immediately apply to improve patient care in real-world clinical settings.

And it doesn’t stop there. When the sessions conclude, the vibrant city of Mumbai opens its arms. Known for its energy, culture, and diversity, Mumbai offers a truly immersive experience. From historic landmarks like the Gateway of India to the peaceful escape of Sanjay Gandhi National Park, and from bustling bazaars to a world-class culinary scene, the city is full of discoveries waiting to be made.

Come for the science. Stay for the experience. We can’t wait to welcome you to this one-of-a-kind event.

On behalf of the UCARE Steering committee and UCARE Conference Committee

Abstract Guidelines

Deadline: 15 October 2025
Length of abstract: max. 300 words
Language: English
Please do not include any figures or tables.
Please add the names, affiliations and addresses of all authors and co-authors.
Repurposed abstracts are ok, original abstracts are preferred.
Presenters need to attend!
Review Processing

We highly recommend keeping the evaluation process as it was done in previous years, since this was very practical, uncomplicated, and clear for all reviewers.

This would mean: After the submission deadline Bluebuds will send an excel sheet with all the information on each abstract (Title, authors, topic, etc.) and an individual evaluation column for each reviewer (Selection options are: Oral, Poster, Reject, no rating as (co-)author) plus a PDF with the abstracts.

The group of reviewers will be divided into two groups so that each reviewer will evaluate approximately 40-50 abstracts. The fact that each abstract is evaluated by 10 reviewers already allows a first rough order. Bluebuds would than close the evaluation process by consolidating the results in one overview.